VitaDAO public
[search 0]
More
Download the App!
show episodes
 
Loading …
show series
 
In this podcast, I (@aging_scientist) spoke with Dr. Rich Miller about the ins and outs of mouse aging. The topics we discussed, roughly in this order, included the Interventions Testing Program, rapamycin, mecilizine, and other lifespan-extending drugs. We talked about the importance of genetically heterogenous mouse stocks and the issues with fas…
  continue reading
 
Slowing aging by a couple of percents would save more money than curing any single disease, be it cancer, heart disease, or diabetes. Aging is, in fact, the major risk factor that all these diseases have in common. For this reason, slowing aging becomes the most efficient path to a sustainable and healthy future for humanity. To get this message ou…
  continue reading
 
Insights on Grant-making and Systemic Change: Lessons from Impetus and Beyond with Martin Borch Jensen & Lada Nuzhna. Outline: 0:00 What is Impetus and how did it get started? 3:12 Takeaways from running and creating Impetus Grants 5:04 Playbook for starting a grant-making program. 12:29 Common misunderstandings between the private sector and acade…
  continue reading
 
Matt Yousefzadeh, Ph.D., is a postdoctoral fellow in the laboratory of Dr. Laura Niedernhofer, Director of the Institute for the Biology of Aging and Metabolism at the University of Minnesota. He is interested in the mechanisms by which endogenous DNA damage and cellular senescence drive aging.
  continue reading
 
Dr. Mathieu is a co-founder and the acting Chief Executive Officer of Sentinel Environmental where they are building better microbiomes. Co-founder of Advanced Microbiotics, a startup focused on developing therapeutics to combat antibiotic-resistant bacteria. Did his Ph.D. in environmental engineering at Rice University.…
  continue reading
 
Richard is a graduate of King’s (BSc, 1993 and PhD, 1996) and following postdoctoral research in the Department of Medicine, University of Cambridge, he joined the School of Cardiovascular Medicine & Sciences at King's as a Lecturer in Nov 2001. He was previously Faculty Vice-Dean (International) between Feb 2017 and Dec 2018 and is currently Facul…
  continue reading
 
Evandro F. Fang is a molecular gerontologist, leading an international anti-aging laboratory at the University of Oslo; his team is composed of 15+ trainees from 7+ countries. He did his PhD with Chair Professor Tzi Bun Ng at the Chinese University of Hong Kong on anti-cancer drug development (Jan. 2009-Dec.)…
  continue reading
 
Join Aubrey de Grey and Vitalik Buterin on our fireside chat where they discuss and answer questions at the intersection of longevity and web3. The AMA is hosted by VitaDAO - VitaDAO is the world’s first decentralized intellectual property collective. Its mission is to extend the human lifespan by collectively financing and commercialising longevit…
  continue reading
 
Meet Laurence Ion - VitaDAO Dealflow Steward, Entrepreneur, longevity advocate and investor. Laurence Ion: https://twitter.com/longevion 0:00 Who are you? What do you do for VitaDAO? 1:02 What fascinates you besides the DAO culture specifically? 3:39 Why did you choose to become a member of a DAO? 5:24 How did you get into the Web3 space? 7:08 What…
  continue reading
 
Dr. Emil Kendziorra is a founder and CEO at Tomorrow Biostasis GmbH based in Berlin, Germany and President of the Board at European Biostasis Foundation, a non-profit research foundation in Switzerland. 00:00 Intro 03:50 What is “Cryopreservation”? 06:58 State of Technology 13:00 When and why opt for “Cryopreservation”? 17:12 Important consideratio…
  continue reading
 
Michael Baran, MBA, Ph.D. is Executive Director, WRDM, and Partner at Pfizer Ventures. Mike is responsible for identifying, evaluating, making, and managing equity investments aligned with the future directions of Pfizer. This talk is part of the 2nd VitaDAO Crypto meets Longevity Symposium! 00:00 Intro 01:47 Creative destruction of Venture Capital…
  continue reading
 
VitaDAO Discussion Panel - Applied Longevity Medicine with Prof. Evelyne Bischof, Prof. Andrea B. Maier and Weronika Prusisz moderated by Max Unfried. Prof. Evelyne Bischof - Longevity Physician at Human Longevity, Inc. and Associate Professor Shanghai University of Medicine&Health Sciences Prof. Andrea B. Maier - National University of Singapore W…
  continue reading
 
Scott Moore is Co-Founder, Developer Relations Lead at Gitcoin, Open Source Enthusiast, Ecosystem Support Group Member at Ethereum. Formerly, Grants Advisory Committee at ConsenSys, Grants Advisory Committee at Ethereum Community Fund, Co-Founder of Finnovate.io, Advisor at Astronaut Capital and Picolo Research, Co-Founder of GitToken. Interview wi…
  continue reading
 
Dr. Tony Kulesa is a founder and Partner at Petri. Previously, he was the founding Director of the MIT BioMakerspace, a community biology laboratory and incubator space, and an Instructor at the MIT Department of Biological Engineering. VitaDAO is the world’s first decentralized intellectual property collective, funding and commissioning research i…
  continue reading
 
Panel Discussion about The Language of Communicating Longevity Hosted by VitaDAO & The Future of Longevity Speakers: Matt Kaeberlein, Morgan Levine, Karl Pfledger, Joao Pedro Magalhaes, Nathan Cheng, Laura Minquini, Max Unfried, Ariella Coler-Reilly, Avi Roy VitaDAO is the world’s first decentralized intellectual property collective, funding and co…
  continue reading
 
Dr. Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Renner…
  continue reading
 
Loading …

Quick Reference Guide